JPRN-C000000142未知未知
PhaseII stady of gefitinib and in patients with relapsed advanced non-small cell lung cancer - PhaseII stady of gefitinib and in patients with relapsed advanced non-small cell lung cancer
Department of Medical Oncology Kinki University School of Medicine0 个研究点目标入组 30 人开始时间: 2005年9月8日最近更新:
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Uncontrolled infection, cardiac disease, hepatic disease, and so on (2)Evidence of interstitial lung disease in chest x-p (3)Active brain metastases (4)Other active malignancy (5)History of bone marrow transplantation (6)History of peripheral blood stem cell transplantation (7)Allergy to any drugs (8)Pregnant or nursing women (9)Patients don't have will of contraception (10)Uncontrolled diabetes (11)Other concurrent serious medical condition
研究者
相似试验
已完成
2 期
Phase II study of gefitinib in untreated advanced non-small cell lung cancer with EGF receptor mutationsnon-small cell lung cancerJPRN-C000000184Hokkaido Lung Cancer Clinical Study Group16
已完成
2 期
Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancernon-small cell lung cancerJPRN-C000000151West Japan Oncology Group25
已完成
2 期
Phase II study of gefitinib therapy inserted by chemotherapy as first line treatment for advanced non-small cell lung cancer harboring epidermal growth factor receptor (EGFR) mutatioon-small-cell lung cancerJPRN-UMIN000001738Thoracic Medical Oncology, National Cancer Center Hospital33
已完成
不适用
A phase II trial of gefitinib in combination with bevacizumab as first line therapy for advanced non-small-cell lung cancer with mutated EGFRnon-small-cell lung cancerJPRN-UMIN000004296Okayama Lung Cancer Study Group42
已完成
2 期
Randomized phase II study of continuous gefitinib plus chemotherapy versus alternation of gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive EGFR mutations (NEJ005/TCOG0902)on-small cell lung cancer with EGFR mutations (non-squamous histology)JPRN-UMIN000002789orth East Japan Study Group/The Tokyo Cooperative Oncology Group80